. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: Neuropsychology. 2016 Nov 10;31(2):160–172. doi: 10.1037/neu0000326

Table 2.

Participant demographic and ADHD features by group (ADHD group on stimulant medication vs. ADHD group not on stimulant medication)

	ADHD (on stimulant medication) (n = 63)	ADHD (not on stimulant medication) (n = 145)
	%	%
Gender (% female)	50.8	51.7
Ethnicity
Hispanic/Latino	6.3	13.1
Race
^**Caucasian	93.7	69.0
^**African American	3.2	15.9
Asian	0.0	3.4
Multiracial	0.0	4.8
Other	3.2	6.9
^**Ethnic/racial diversity	9.5	36.6
1 or more comorbid disorder(s)	61.9	60.7
	M (SD)	M (SD)
Age	18.22 (0.61)	18.26 (0.50)
CAARS DSM-IV IN	79.25 (11.88)	78.16 (12.43)
CAARS DSM-IV HI	61.21 (14.71)	64.30 (12.80)
CAARS Total ADHD	72.92 (15.37)	74.84 (12.61)

Note. ADHD = Attention-deficit/hyperactivity disorder; CAARS = Conners Adult ADHD Rating Scale; DSM = Diagnostic and Statistical Manual of Mental Disorders; IN = Inattention T score; HI = Hyperactivity-Impulsivity T score

^**

group difference statistically significant at 0.01 level